Skip to main content

Peer Review reports

From: TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro

Original Submission
22 Jun 2023 Submitted Original manuscript
13 Jul 2023 Reviewed Reviewer Report - Zhang-Yu Zou
28 Jul 2023 Reviewed Reviewer Report
31 Jul 2023 Reviewed Reviewer Report
8 Oct 2023 Author responded Author comments - Qing-Qing Duan
Resubmission - Version 2
8 Oct 2023 Submitted Manuscript version 2
22 Oct 2023 Reviewed Reviewer Report - Zhang-Yu Zou
5 Nov 2023 Reviewed Reviewer Report
23 Nov 2023 Reviewed Reviewer Report
5 Dec 2023 Author responded Author comments - Qing-Qing Duan
Resubmission - Version 3
5 Dec 2023 Submitted Manuscript version 3
4 Jan 2024 Reviewed Reviewer Report
23 Jan 2024 Author responded Author comments - Qing-Qing Duan
Resubmission - Version 4
23 Jan 2024 Submitted Manuscript version 4
6 Feb 2024 Reviewed Reviewer Report
22 Feb 2024 Author responded Author comments - Qing-Qing Duan
Resubmission - Version 5
22 Feb 2024 Submitted Manuscript version 5
Publishing
23 Feb 2024 Editorially accepted
5 Mar 2024 Article published 10.1186/s12916-024-03314-1

You can find further information about peer review here.

Back to article page